معرفی
Merab Kokaia is a renowned Professor in the Division of Neurology at Lund University (since 2008) and Chavchavadze State University (since 2011). His career spans over three decades, including roles as Director of the Epilepsy Center at Lund University (since 2013) and coordinator of the EU FP7 EPITARGET project (2013-2018). He has held academic positions across Sweden, Georgia, and the UK, with expertise in epilepsy, neuroscience, and neurophysiology.
- 1998 Docent Degree in Experimental Neurology, Lund University
- 1991 Doctor of Biological Sciences in Neuroscience, Georgian Academy of Sciences
- 1983 PhD in Neurophysiology, Georgian Academy of Sciences
- 1978 BA in Biology, Tbilisi State University
His research focuses on epilepsy, optogenetics, and gene therapy, with significant contributions to neurotrophic factors and chemogenetics. He has coordinated large-scale EU-funded projects and supervised 16 PhD students, 12 postdocs, and over 26 graduate students.
Kokaia has secured major grants including the EC FP7 EPITARGET (€12M as Coordinator) and Marie Curie Train4CRS, and holds patents for neuroprotective agents and gene therapy applications in neurological disorders.
- Elected Honorary foreign member of Georgian Academy of Sciences (2017)
- Elected Member of Swedish Royal Academy (Kungl. Fysiografiska Sällskapet) (2011)
